Meanwhile, a growing number of companies are offering a new commercial service: direct-to-consumer analysis of DNA for genealogical or medical purposes. While their activities and clientele are steadily increasing, many of the results currently are of only limited value for determining physical and behavioral characteristics or risks of common diseases such as hypertension, cardiovascular diseases, diabetes, and depression.
与此同时，越来越多的公司在提供一项新的商业服务：面向消费者的出于血统和医疗目的的DNA分析。尽管它们的活动和客户在稳步增长，但许多结果目前对于确定生理和行为特征或患高血压、心血管疾病、糖尿病和抑郁症等疾病风险价值有限。